PATENT CLAIM ANALYSIS

Application Number: 15996544
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-09
Patent Classification: ["514", "218000"]

Abstract:
Provided are novel compounds which are capable of inhibiting an activity of RNA polymerase I, and uses thereof in treating diseases or disorders modulated by RNA polymerase I, preferably autoimmune diseases such as multiple sclerosis and proliferative diseases.

Claim (Index 1):
A method of treating relapsing-remitting multiple sclerosis in a subject, the method comprising administering to the subject a therapeutically effective amount of the compound represented by Formula Ib: wherein G is selected from the group consisting of hydrogen, alkyl, cycloalkyl, aryl, heteroaryl, heteroalicyclic, alkoxy, thioalkoxy, thiol, hydroxyl, aryloxy, and thioaryloxy.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.28125
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14742907', '14935155', '15485106', '15661770', '14708230']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6940594505421693
- 35 USC 102 Novelty (BERT): 0.5448444909263126
- Combined Prediction Score: 0.6791379545805837
- Mean Citation Score: 213.92281000000003
- Max Citation Score: 380.62625
- Similarity Product: 236.3556035283953

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test